Long-Term Debt: The sum of all long term debt fields.
Allarity Therapeutics, Inc. (ALLR) Long-Term Debt data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.40M |
|
-- |
|
-- |
|
$2.67M |
|
$-2.67M |
|
$-0.73M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
$-2.67M |
|
$-2.64M |
|
15.91M |
|
15.91M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$31.73M |
|
$0.39M |
|
$0.39M |
|
$32.12M |
|
$28.58M |
|
|
Long-Term Debt |
-- |
-- |
|
$28.58M |
|
$3.54M |
|
$3.54M |
|
$3.54M |
|
15.91M |
|
| Cash Flow Statement Financials | |
$-7.06M |
|
$-0.06M |
|
$19.74M |
|
$14.69M |
|
$26.98M |
|
$12.29M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
-- |
|
6.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-96.30% |
|
-96.30% |
|
-10.60% |
|
-96.30% |
|
$0.22 |
|
$-0.45 |
|
$-0.44 |
|